Prurigo Nodularis Associated With GI and Hepatobiliary Diseases in Adults
Researchers investigated the link between prurigo nodularis and both gastrointestinal and hepatobiliary conditions.
Prurigo Nodularis
Prurigo Nodularis Tied to Significant Economic and Quality of Life Burden
The effect of prurigo nodularis on quality of life and its economic burden are investigated.
Significant Improvements Observed With Dupilumab in Prurigo Nodularis Trial
The phase 3 PRIME study evaluated dupilumab in 151 adults with inadequately controlled prurigo nodularis.
Trust Your Gut: Diagnosis and Treatment of Keto Rash
Author reviews a case of prurigo pigmentosa in a patient following the ketogenic diet and outlines a strategy to diagnose and treat this condition.
Dupilumab Reduced Itch, Skin Lesions in Patients With Prurigo Nodularis
The randomized, double-blind, placebo-controlled, parallel-group PRIME2 study included 160 patients with prurigo nodularis.
Expert Roundtable: Racial Disparities in Dermatology Care
A roundtable discussion by experts in issues facing patients with skin of color reveals interesting insights.
Skin of Color Disproportionately Affected by Cutaneous Disorders
The racial and ethnic distribution of common dermatologic disorders seen at a US tertiary care center are characterized.
Intranasal Butorphanol Effectively Reduces Pruritus
One of the largest case series of intranasal butorphanol rescue therapy in treating intractable itch demonstrates success.
Prurigo Nodularis, Lichen Simplex Chronicus Linked to Range of Mental Health Disorders
In a multivariable logistic regression, PN and LSC were associated with having 1 or more mental health disorders.
Serlopitant Not Statistically Significantly Better Than Placebo in Prurigo Nodularis Studies
Menlo Therapeutics announced topline results from two phase 3 studies of serlopitant for the treatment of pruritus associated with prurigo nodularis.
- Loading...
Loading...
Next post in General Dermatology
Loading... 
Loading...